National Voluntary Blood Services

Blood Safety Indicators Report Form 2018

Program
v.1.1
Section 1: Administrative Information
1.1 Date April 18, 2018
1.2 Region 12
Please base your
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center classification on your
license during the period
1.4 Classification Blood Center covered by the report
Information provided by: Bloodbank
head
1.5 Name Dr. Nena S. Lingayon, AP-CP
1.6 Position Pathologist
1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail manz.franz@yahoo.com
1.12 Period covered by report JANUARY TO MARCH 2018
Section 2: Blood Donors and blood collection
2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 2,082
2.3.2 Total number of voluntary non-remunerated donors who donated blood 1,681
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 113
2.4.2 Temporary deferral 221
2.4.3 Total number of deferrals 334
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 171
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 35
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 113
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 15
2.5.5 Total number of deferrals 334
Low haemoglobin + Other Me
2.6 How many whole blood donations were collected, by types of donation? Conditions + High-risk behav
2.6.1 Voluntary non-remunerated donations 1,681 Travel and other reasons
2.6.2 Family/replacement donations 401
2.6.3 Paid donations 0
2.6.4 Total number of donations 2,082
Voluntary non-remunerated d
2.7 How many whole blood donations were collected from: Family/replacement donation
2.7.1 Male donors 1,675 + Others
2.7.2 Female donors 407
 2.7.3 Total number of donations 2,082
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 22
2.8.2 Donors aged 18 to 24 years 442
2.8.3 Donors aged 25 to 44 years 1,345
2.8.4 Donors aged 45 to 64 years 273
2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 2082
2.9 How many whole blood donations were collected from first-time voluntary non- 816
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 1.0000
Voluntary Non-remunerated
2.11 Are any blood donations collected through apheresis procedures? donations
If yes, how many apheresis donations were collected by types of donation? Total number of non-remune
donors who donated blood
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify):
2.11.5 Total number of apheresis donations
2.11.6 Total number of donors who donated through apheresis procedures
Voluntary non-remunerated
during reporting period apheresis donations +
2.12 Do you have a system for post-donation counselling of blood donors who test positive Family/replacement apheres
for transfusion-transmissible infections? donations + Paid apheresis d
+ Others

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do you Douse
youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 1,744 83.77%
3.4.2 Hepatitis B 1,744 83.77% Total donations screened
Total donations
3.4.3 Hepatitis C 1,744 83.77%
3.4.4 Syphilis 1,744 83.77%
3.4.5 Malaria 1,744 83.77%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 8 0.46% 0.00%
3.5.2 Hepatitis B 72 4.13% Screening test
0.00%
reactive
Total donations screened
3.5.3 Hepatitis C 5 0.29% 0.00%
3.5.4 Syphilis 27 1.55% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performance
Number of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
 2,082 2,082 2,082 2,082 2,082 2,082
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external
evaluation of performance for blood serology?

Section 5: Blood component preparation, storage and transportation Whole blood separated into
components
5.1 Do you prepare blood components? total number of Donations
5.2 How many whole blood donations were separated into components? 79 3.79%
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 79
5.3.2 Platelet concentrates 79
5.3.3 Plasma 0
5.3.4 Fresh Frozen Plasma 79
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells
5.4.2 Apheresis platelets Apheresis red cells + Apheres
5.4.3 Apheresis plasma platelets + Apheresis Plasma

5.4.5 Total blood components

5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection?
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 113 38 5 156
5.11.2 Red cells 1 2 3
5.11.3 Platelets 1 6 4 11
 5.11.4 Plasma
5.11.5 Fresh frozen plasma 1 65 66
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 116 44 76 236
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years 18 27
6.5.2 Patients aged 5 to 14 years 18 17
6.5.3 Patients aged 15 to 44 years 170 495
6.5.4 Patients aged 45 to 59 years 258 221
6.5.5 Patients aged 60 years older 236 245
6.5.6 Total number of patients transfused by gender 700 1005
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
ur
n your
he period
report

FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

bin + Other Medical

igh-risk behaviour +
er reasons

remunerated donations +
ment donations + Paid donations
remunerated

f non-remunerated
FALSE
nated blood

remunerated
tions +
ment apheresis
id apheresis donations

FALSE

FALSE
1
FALSE
FALSE

s screened
s
 FALSE FALSE

FALSE
FALSE
FALSE
FALSE

FALSE

1
FALSE
FALSE
FALSE
parated into

f Donations 3

ells + Apheresis
heresis Plasma

1
1
1
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
Program
v.1.1
Section 1: Administrative Information
1.1 Date February 5, 2020
1.2 Region 12
Please base
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center classification
1.4 Classification Blood Center license durin
covered
Bloodbankby t
Information provided by: head
1.5 Name Dr. Nena S. Lingayon, AP-CP
1.6 Position Pathologist
1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report January-20
Section 2: Blood Donors and blood collection
2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 586
2.3.2 Total number of voluntary non-remunerated donors who donated blood 338
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 31
2.4.2 Temporary deferral 174
2.4.3 Total number of deferrals 205
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 44
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 130
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 26
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 0 Low haemog
2.5.5 Total number of deferrals 200 Conditions +
Travel and o
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 338
2.6.2 Family/replacement donations 248
 2.6.3 Paid donations 0 Voluntary no
2.6.4 Total number of donations 586 Family/repla
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 448
2.7.2 Female donors 138
2.7.3 Total number of donations 586
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 0
2.8.2 Donors aged 18 to 24 years 115
2.8.3 Donors aged 25 to 44 years 392
2.8.4 Donors aged 45 to 64 years 79
2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 586
2.9 How many whole blood donations were collected from first-time voluntary non- 81
remunerated donors? Voluntary No
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 1.0000 donations
Total numbe
2.11 Are any blood donations collected through apheresis procedures? donors who
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify):
Voluntary no
2.11.5 Total number of apheresis donations apheresis do
2.11.6 Total number of donors who donated through apheresis procedures Family/repla
during reporting period donations +
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do you Douse
youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 461 78.67%
3.4.2 Hepatitis B 461 78.67% Total donatio
Total donatio
3.4.3 Hepatitis C 461 78.67%
3.4.4 Syphilis 461 78.67%
3.4.5 Malaria 461 78.67%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 1 0.22% 0.00%
3.5.2 Hepatitis B 20 4.34% Screening 0.00%
test reactive
Total donations screened
3.5.3 Hepatitis C 2 0.43% 0.00%
3.5.4 Syphilis 6 1.30% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
 What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performance
Number of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
461 461 461 461 461 461
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation Whole blood

components
5.1 Do you prepare blood components? total number
5.2 How many whole blood donations were separated into components? 0 0.00%
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 0
5.3.2 Platelet concentrates 0
5.3.3 Plasma 0
5.3.4 Fresh Frozen Plasma 0
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells
5.4.2 Apheresis platelets Apheresis re
5.4.3 Apheresis plasma platelets + A

5.4.5 Total blood components

5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
 5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection?
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 26 72 98
5.11.2 Red cells 0 0 0
5.11.3 Platelets 0 0 0
5.11.4 Plasma
5.11.5 Fresh frozen plasma 0 0 0
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 26 72 98
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
6.5.4 Patients aged 45 to 59 years
6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
 6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
Please base your
classification on your
license during the period
covered
Bloodbankby the report
head

1
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

Low haemoglobin + Other Medical

Conditions + High-risk behaviour +
Travel and other reasons
 Voluntary non-remunerated donations +
Family/replacement donations + Paid donations
+ Others

Voluntary Non-remunerated
donations
Total number of non-remunerated
donors who donated blood
FALSE

Voluntary non-remunerated
apheresis donations +
Family/replacement apheresis
donations + Paid apheresis donations
+ Others

FALSE

FALSE
1
FALSE
FALSE

Total donations screened

Total donations

eactive
screened
 FALSE FALSE

FALSE
FALSE
FALSE
FALSE

FALSE

1
FALSE

FALSE
FALSE
Whole blood separated into
components
total number of Donations 3

Apheresis red cells + Apheresis

platelets + Apheresis Plasma

1
1
1
1
1
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
Program
v.1.1
Section 1: Administrative Information
1.1 Date March 3, 2020
1.2 Region 12
Please base
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center classification
1.4 Classification Blood Center license durin
covered
Bloodbankby t
Information provided by:
head
1.5 Name Dr. Nena S. Lingayon, AP-CP
1.6 Position Pathologist
1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report February-20
Section 2: Blood Donors and blood collection
2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 677
2.3.2 Total number of voluntary non-remunerated donors who donated blood 595
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 26
2.4.2 Temporary deferral 85
2.4.3 Total number of deferrals 111
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 17
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 68
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 26
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 0
Low haemog
2.5.5 Total number of deferrals 111 Conditions +
2.6 How many whole blood donations were collected, by types of donation? Travel and o

2.6.1 Voluntary non-remunerated donations 595

2.6.2 Family/replacement donations 82
 2.6.3 Paid donations 0
Voluntary no
2.6.4 Total number of donations 677 Family/repla
2.7 How many whole blood donations were collected from: + Others

2.7.1 Male donors 505

2.7.2 Female donors 172
2.7.3 Total number of donations 677
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 0
2.8.2 Donors aged 18 to 24 years 178
2.8.3 Donors aged 25 to 44 years 418
2.8.4 Donors aged 45 to 64 years 81
2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 677
2.9 How many whole blood donations were collected from first-time voluntary non-remunerated
donors?
227
Voluntary No
donations
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 1.0000 Total numbe
2.11 Are any blood donations collected through apheresis procedures? donors who

If yes, how many apheresis donations were collected by types of donation?

2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify): Voluntary no
2.11.5 Total number of apheresis donations apheresis do
2.11.6 Total number of donors who donated through apheresis procedures Family/repla
donations +
during reporting period + Others
2.12 Do you have a system for post-donation counselling of blood donors who test positive
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do you Douse
youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
3.3 Do you participate in an external quality assessment scheme/external
infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 494 72.97% Total donatio
3.4.2 Hepatitis B 494 72.97% Total donatio
3.4.3 Hepatitis C 494 72.97%
3.4.4 Syphilis 494 72.97%
3.4.5 Malaria 494 72.97%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 5 1.01% 0.00%
Screening test reactive
3.5.2 Hepatitis B 17 3.44% Total donations
0.00%
screened
3.5.3 Hepatitis C 1 0.20% 0.00%
3.5.4 Syphilis 4 0.81% 0.00%
 3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performance
Number of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
494 494 494 494 494 494
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Whole blood
Section 5: Blood component preparation, storage and transportation
components
5.1 Do you prepare blood components? total number

5.2 How many whole blood donations were separated into components? 25 3.69%
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 25
5.3.2 Platelet concentrates 25
5.3.3 Plasma 0
5.3.4 Fresh Frozen Plasma 25
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells
5.4.2 Apheresis platelets Apheresis re
platelets + A
5.4.3 Apheresis plasma
5.4.5 Total blood components
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
 5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 22 22
5.11.2 Red cells 0 0
5.11.3 Platelets 0 0
5.11.4 Plasma
5.11.5 Fresh frozen plasma 0 0
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 22 22
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
6.5.4 Patients aged 45 to 59 years
6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
 6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
Please base your
classification on your
license during the period
covered
Bloodbankby the report
head

1
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

Low haemoglobin + Other Medical

Conditions + High-risk behaviour +
Travel and other reasons
 Voluntary non-remunerated donations +
Family/replacement donations + Paid donations
+ Others

Voluntary Non-remunerated
donations
Total number of non-remunerated
donors who donated blood

FALSE

Voluntary non-remunerated
apheresis donations +
Family/replacement apheresis
donations + Paid apheresis donations
+ Others

FALSE

FALSE
1
FALSE
FALSE
Total donations screened
Total donations

eactive
screened
 FALSE FALSE

FALSE
FALSE
FALSE
FALSE

FALSE

1
FALSE

FALSE
FALSE
Whole blood separated into
components
total number of Donations 3

Apheresis red cells + Apheresis

platelets + Apheresis Plasma

1
1
1
1
1
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date April 2, 2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base
1.4 Classification Blood Center classification
license durin
Information provided by: covered
Bloodbankby t

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report March-20
Section 2: Blood Donors and blood collection
2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 354
2.3.2 Total number of voluntary non-remunerated donors who donated blood 333
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 27
2.4.2 Temporary deferral 109
2.4.3 Total number of deferrals 136
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 84
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 25
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 27
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 0
2.5.5 Total number of deferrals 136 Low haemog
Conditions +
2.6 How many whole blood donations were collected, by types of donation? Travel and o
2.6.1 Voluntary non-remunerated donations 333
2.6.2 Family/replacement donations 21
 2.6.3 Paid donations 0
2.6.4 Total number of donations 354 Voluntary no
Family/repla
2.7 How many whole blood donations were collected from: + Others
2.7.1 Male donors 277
2.7.2 Female donors 77
2.7.3 Total number of donations 354
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 1
2.8.2 Donors aged 18 to 24 years 74
2.8.3 Donors aged 25 to 44 years 219
2.8.4 Donors aged 45 to 64 years 59
2.8.5 Donors aged 65 years or older 1
2.8.6 Total number of donations 354
2.9 How many whole blood donations were collected from first-time voluntary non- 83
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 1.0000 Voluntary No
donations
2.11 Are any blood donations collected through apheresis procedures? Total numbe
donors who
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify):
2.11.5 Total number of apheresis donations Voluntary no
2.11.6 Total number of donors who donated through apheresis procedures apheresis do
during reporting period Family/repla
2.12 Do you have a system for post-donation counselling of blood donors who test positive donations +
for transfusion-transmissible infections? + Others

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do you Douse
youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
3.3 Do you participate in an external quality assessment scheme/external
infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 511 144.35%
3.4.2 Hepatitis B 511 144.35%
3.4.3 Hepatitis C 511 144.35% Total donatio
Total donatio
3.4.4 Syphilis 511 144.35%
3.4.5 Malaria 511 144.35%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 0 0.00% 0.00%
3.5.2 Hepatitis B 21 4.11% 0.00%
3.5.3 Hepatitis C 2 0.39% Screening test reactive
0.00%
Total donations screened
3.5.4 Syphilis 5 0.98% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
 3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performance
Number of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
511 511 511 511 511 511
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components?
Whole blood
5.2 How many whole blood donations were separated into components? 18 5.08% components
5.3 How many units of blood components were prepared from whole blood donations? total number

Component
5.3.1 Red cell preparations 18
5.3.2 Platelet concentrates 18
5.3.3 Plasma 0
5.3.4 Fresh Frozen Plasma 18
5.3.5 Cryoprecipitate 0
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells
5.4.2 Apheresis platelets
5.4.3 Apheresis plasma
5.4.5 Total blood components Apheresis re
platelets + A
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
 5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 22 22
5.11.2 Red cells 0 0
5.11.3 Platelets 0 0
5.11.4 Plasma
5.11.5 Fresh frozen plasma 0 0
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 22 22
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
6.5.4 Patients aged 45 to 59 years
6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
 6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
Please base your
classification on your
license during the period
covered
Bloodbankby the report
head

1
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

Low haemoglobin + Other Medical

Conditions + High-risk behaviour +
Travel and other reasons
 Voluntary non-remunerated donations +
Family/replacement donations + Paid donations
+ Others

Voluntary Non-remunerated
donations
Total number of non-remunerated
donors who donated blood
FALSE

Voluntary non-remunerated
apheresis donations +
Family/replacement apheresis
donations + Paid apheresis donations
+ Others
FALSE

FALSE
1
FALSE
FALSE

Total donations screened

Total donations

eactive
screened
 FALSE FALSE

FALSE
FALSE
FALSE
FALSE

FALSE
1
FALSE
FALSE
FALSE

3
Whole blood separated into
components
total number of Donations

Apheresis red cells + Apheresis

platelets + Apheresis Plasma

1
1
1
1
1
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date April 15, 2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on
license during th
Information provided by: covered
Bloodbankby the r

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report JANUARY TO MARCH 2020

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 1,617
2.3.2 Total number of voluntary non-remunerated donors who donated blood 1,266
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 84
2.4.2 Temporary deferral 368
2.4.3 Total number of deferrals 452
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 145
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 223
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 79
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 0 Low haemogl
2.5.5 Total number of deferrals 447 Conditions +
Travel and ot
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 1,266
2.6.2 Family/replacement donations 351
2.6.3 Paid donations 0 Voluntary no
2.6.4 Total number of donations 1,617 Family/repla
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 1,230
2.7.2 Female donors 387
 2.7.3 Total number of donations 1,617
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 1
2.8.2 Donors aged 18 to 24 years 367
2.8.3 Donors aged 25 to 44 years 1,029
2.8.4 Donors aged 45 to 64 years 219
2.8.5 Donors aged 65 years or older 1
2.8.6 Total number of donations 1617
2.9 How many whole blood donations were collected from first-time voluntary non- 391 Voluntary No
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 1.0000 donations
Total number
2.11 Are any blood donations collected through apheresis procedures? donors who d
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify): Voluntary no
2.11.5 Total number of apheresis donations apheresis don
2.11.6 Total number of donors who donated through apheresis procedures during Family/repla
reporting period donations + P
2.12 Do you have a system for post-donation counselling of blood donors who test positive for + Others
transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1 Do you use EIA for screening blood donations for TTIs?
3.2 Do you use standard operating procedures or local written instructions for
laboratory screening of blood donations for transfusion transmissible infections?
3.3 Do you participate in an external quality assessment scheme/external evaluation
or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 1,466 90.66%
3.4.2 Hepatitis B 1,466 90.66% Total donatio
Total donatio
3.4.3 Hepatitis C 1,466 90.66%
3.4.4 Syphilis 1,466 90.66%
3.4.5 Malaria 1,466 90.66%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory
TTI Markers
reactive test positive
3.5.1 HIV 6 0.41% 0.00%
3.5.2 Hepatitis B 58 3.96% Screening 0.00%
test reactive
3.5.3 Hepatitis C 5 0.34% Total donations
0.00% screened

3.5.4 Syphilis 15 1.02% 0.00%

3.5.5 Malaria 0 0.00% 0.00%
3.6 What was the prevalence of the following TTI markers in donated blood during the reporting period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation of
performance
Total Number of donations screened for each TTI SOPs used Participate in EQA
donations HIV HBV HCV Syphilis Malaria Yes No Yes No
1,466 1,466 1,466 1,466 1,466 1,466
 3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation
of performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood
components
5.2 How many whole blood donations were separated into components? 43 2.66% total number
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 43
5.3.2 Platelet concentrates 43
5.3.3 Plasma 0
5.3.4 Fresh Frozen Plasma 43
5.3.5 Cryoprecipitate 0
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells 0
5.4.2 Apheresis platelets 0
5.4.3 Apheresis plasma 0 Apheresis red
platelets + A
5.4.5 Total blood components 0
5.5 Do you use standard operating procedures or local written instructions for the preparation
of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU expiry
Total
S
5.11.1 Whole blood 70 72 142
5.11.2 Red cells
5.11.3 Platelets
5.11.4 Plasma
5.11.5 Fresh frozen plasma
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 70 72 142
 HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions for
compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years 25 7
6.5.2 Patients aged 5 to 14 years 19 19
6.5.3 Patients aged 15 to 44 years 262 557
6.5.4 Patients aged 45 to 59 years 255 209
6.5.5 Patients aged 60 years older 221 198
6.5.6 Total number of patients transfused by gender 782 990
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood 1,555
6.6.2 Red cells 202
6.6.3 Plasma and fresh frozen plasma 40
6.6.4 Platelets, whole blood-derive 54
6.6.5 Platelets, apheresis 0
6.6.6 Cryoprecipitate 0
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
Please base your
classification on your
license during the period
covered
Bloodbankby the report
head

1
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

Low haemoglobin + Other Medical

Conditions + High-risk behaviour +
Travel and other reasons

Voluntary non-remunerated donations +

Family/replacement donations + Paid donations
+ Others
 Voluntary Non-remunerated
donations
Total number of non-remunerated
donors who donated blood
FALSE

Voluntary non-remunerated
apheresis donations +
Family/replacement apheresis
donations + Paid apheresis donations
+ Others

FALSE

FALSE
1
FALSE
FALSE

Total donations screened

Total donations

ening test reactive

al donations screened
 FALSE FALSE

FALSE
FALSE
FALSE
FALSE

FALSE
1
FALSE
FALSE
FALSE

Whole blood separated into3

components
total number of Donations

Apheresis red cells + Apheresis

platelets + Apheresis Plasma

1
1
1
1
1
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date May 15, 2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on your
license during the period
Information provided by: covered
Bloodbankby the report

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report April-20

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 234
2.3.2 Total number of voluntary non-remunerated donors who donated blood 0
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 11
2.4.2 Temporary deferral 16
2.4.3 Total number of deferrals 27
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 9
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 7
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 11
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 0 Low haemoglobin + Oth
2.5.5 Total number of deferrals 27 Conditions + High-risk b
Travel and other reasons
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 0
2.6.2 Family/replacement donations 234
2.6.3 Paid donations 0 Voluntary non-remunera
2.6.4 Total number of donations 234 Family/replacement don
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 209
2.7.2 Female donors 25
2.7.3 Total number of donations 234
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 0
2.8.2 Donors aged 18 to 24 years 47
2.8.3 Donors aged 25 to 44 years 162
2.8.4 Donors aged 45 to 64 years 25
 2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 234
2.9 How many whole blood donations were collected from first-time voluntary non- 0 Voluntary Non-remunera
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 0.0000 donations
Total number of non-rem
2.11 Are any blood donations collected through apheresis procedures? donors who donated blo
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify): Voluntary non-remunera
2.11.5 Total number of apheresis donations apheresis donations +
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement aph
during reporting period donations + Paid aphere
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do youDouse
youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 233 99.57%
3.4.2 Hepatitis B 233 99.57% Total donations screened
3.4.3 Hepatitis C 233 99.57% Total donations
3.4.4 Syphilis 233 99.57%
3.4.5 Malaria 233 99.57%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 1 0.43% 0.00%
3.5.2 Hepatitis B 6 2.58% Screening test 0.00%
reactive
3.5.3 Hepatitis C 0 0.00% Total donations screened
0.00%
3.5.4 Syphilis 4 1.72% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performance
Number of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
233 233 233 233 233 233
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
 4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separated i
components
5.2 How many whole blood donations were separated into components? 54 23.08% total number of Donation
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 54
5.3.2 Platelet concentrates 54
5.3.3 Plasma
5.3.4 Fresh Frozen Plasma 54
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells 0
5.4.2 Apheresis platelets 0
5.4.3 Apheresis plasma 0 Apheresis red cells + Ap
platelets + Apheresis Pla
5.4.5 Total blood components 0
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 9 9 0 5 22 45
5.11.2 Red cells 0 0 0 0 0 0
5.11.3 Platelets 0 0 0 0 18 18
5.11.4 Plasma
5.11.5 Fresh frozen plasma 0 0 0 0 0 0
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 9 9 0 5 40 63
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
6.5.4 Patients aged 45 to 59 years
 6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
Please base your
classification on your
license during the period
covered
Bloodbankby the report
head

1
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

Low haemoglobin + Other Medical

Conditions + High-risk behaviour +
Travel and other reasons

Voluntary non-remunerated donations +

Family/replacement donations + Paid donations
+ Others
 Voluntary Non-remunerated
donations
Total number of non-remunerated
donors who donated blood
FALSE

Voluntary non-remunerated
apheresis donations +
Family/replacement apheresis
donations + Paid apheresis donations
+ Others

FALSE

FALSE
1
FALSE
FALSE

Total donations screened

Total donations

active
creened

FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
1
FALSE
 FALSE
FALSE

Whole blood separated into 3

components
total number of Donations

Apheresis red cells + Apheresis

platelets + Apheresis Plasma

1
1
1
1
1
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date June 12, 2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on your
license during the period
Information provided by: covered
Bloodbankby the report

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report May-20

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 345
2.3.2 Total number of voluntary non-remunerated donors who donated blood 125
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 18
2.4.2 Temporary deferral 13
2.4.3 Total number of deferrals 31
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 8
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 5
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 18
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 0 Low haemoglobin + Oth
2.5.5 Total number of deferrals 31 Conditions + High-risk b
Travel and other reasons
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 125
2.6.2 Family/replacement donations 220
2.6.3 Paid donations 0 Voluntary non-remunera
2.6.4 Total number of donations 345 Family/replacement don
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 274
2.7.2 Female donors 71
2.7.3 Total number of donations 345
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 0
2.8.2 Donors aged 18 to 24 years 72
2.8.3 Donors aged 25 to 44 years 229
2.8.4 Donors aged 45 to 64 years 43
 2.8.5 Donors aged 65 years or older 1
2.8.6 Total number of donations 345
2.9 How many whole blood donations were collected from first-time voluntary non- 38 Voluntary Non-remunera
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 0.0000 donations
Total number of non-rem
2.11 Are any blood donations collected through apheresis procedures? donors who donated blo
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify): Voluntary non-remunera
2.11.5 Total number of apheresis donations apheresis donations +
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement aph
during reporting period donations + Paid aphere
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do you Douse
youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 329 95.36%
3.4.2 Hepatitis B 329 95.36% Total donations screened
3.4.3 Hepatitis C 329 95.36% Total donations
3.4.4 Syphilis 329 95.36%
3.4.5 Malaria 329 95.36%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 0 0.00% 0.00%
3.5.2 Hepatitis B 11 3.34% Screening test 0.00%
reactive
3.5.3 Hepatitis C 3 0.91% Total donations screened
0.00%
3.5.4 Syphilis 5 1.52% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performance
Number of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
329 329 329 329 329 329
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
 4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separated i
components
5.2 How many whole blood donations were separated into components? 14 4.06% total number of Donation
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 14
5.3.2 Platelet concentrates 14
5.3.3 Plasma
5.3.4 Fresh Frozen Plasma 14
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells
5.4.2 Apheresis platelets
5.4.3 Apheresis plasma Apheresis red cells + Ap
platelets + Apheresis Pla
5.4.5 Total blood components
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 44 5 1 52 26 128
5.11.2 Red cells 0 0 0 0 1 1
5.11.3 Platelets 0 0 0 0 31 31
5.11.4 Plasma
5.11.5 Fresh frozen plasma 0 0 0 1 0 1
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 44 5 1 53 58 161
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
6.5.4 Patients aged 45 to 59 years
 6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
Please base your
classification on your
license during the period
covered
Bloodbankby the report
head

3
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

Low haemoglobin + Other Medical

Conditions + High-risk behaviour +
Travel and other reasons

Voluntary non-remunerated donations +

Family/replacement donations + Paid donations
+ Others
 Voluntary Non-remunerated
donations
Total number of non-remunerated
donors who donated blood
FALSE

Voluntary non-remunerated
apheresis donations +
Family/replacement apheresis
donations + Paid apheresis donations
+ Others

FALSE

FALSE
3
FALSE
FALSE

Total donations screened

Total donations

active
creened

FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
 FALSE
FALSE

Whole blood separated into

FALSE
components
total number of Donations

Apheresis red cells + Apheresis

platelets + Apheresis Plasma

FALSE
FALSE
FALSE
FALSE
FALSE
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date July 4, 2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on your
license during the period
Information provided by: covered
Bloodbankby the report

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report June-20

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 728
2.3.2 Total number of voluntary non-remunerated donors who donated blood 485
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 30
2.4.2 Temporary deferral 15
2.4.3 Total number of deferrals 45
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 4
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 11
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 30
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 0 Low haemoglobin + Oth
2.5.5 Total number of deferrals 45 Conditions + High-risk b
Travel and other reasons
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 485
2.6.2 Family/replacement donations 243
2.6.3 Paid donations 0 Voluntary non-remunera
2.6.4 Total number of donations 728 Family/replacement don
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 549
2.7.2 Female donors 179
2.7.3 Total number of donations 728
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 1
2.8.2 Donors aged 18 to 24 years 185
2.8.3 Donors aged 25 to 44 years 437
2.8.4 Donors aged 45 to 64 years 105
 2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 728
2.9 How many whole blood donations were collected from first-time voluntary non- 111 Voluntary Non-remunera
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 0.0000 donations
Total number of non-rem
2.11 Are any blood donations collected through apheresis procedures? donors who donated blo
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify): Voluntary non-remunera
2.11.5 Total number of apheresis donations apheresis donations +
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement aph
during reporting period donations + Paid aphere
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do you Douse
youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 518 71.15%
3.4.2 Hepatitis B 518 71.15% Total donations screened
3.4.3 Hepatitis C 518 71.15% Total donations
3.4.4 Syphilis 518 71.15%
3.4.5 Malaria 518 71.15%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 0 0.00% 0.00%
3.5.2 Hepatitis B 21 4.05% Screening test 0.00%
reactive
3.5.3 Hepatitis C 4 0.77% Total donations screened
0.00%
3.5.4 Syphilis 6 1.16% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performance
Number of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
518 518 518 518 518 518
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
 4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separated i
components
5.2 How many whole blood donations were separated into components? 0 0.00% total number of Donation
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 0
5.3.2 Platelet concentrates 0
5.3.3 Plasma 0
5.3.4 Fresh Frozen Plasma 0
5.3.5 Cryoprecipitate 0
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells 0
5.4.2 Apheresis platelets 0
5.4.3 Apheresis plasma 0 Apheresis red cells + Ap
platelets + Apheresis Pla
5.4.5 Total blood components 0
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 63 0 0 14 10 87
5.11.2 Red cells 0 0 0 0 2 2
5.11.3 Platelets 0 0 0 0 32 32
5.11.4 Plasma
5.11.5 Fresh frozen plasma 0 0 0 0 30 30
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 63 0 0 14 74 151
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
6.5.4 Patients aged 45 to 59 years
 6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
Please base your
classification on your
license during the period
covered
Bloodbankby the report
head

3
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

Low haemoglobin + Other Medical

Conditions + High-risk behaviour +
Travel and other reasons

Voluntary non-remunerated donations +

Family/replacement donations + Paid donations
+ Others
 Voluntary Non-remunerated
donations
Total number of non-remunerated
donors who donated blood
FALSE

Voluntary non-remunerated
apheresis donations +
Family/replacement apheresis
donations + Paid apheresis donations
+ Others

FALSE

FALSE
3
FALSE
FALSE

Total donations screened

Total donations

active
creened

FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
 FALSE
FALSE

Whole blood separated into

FALSE
components
total number of Donations

Apheresis red cells + Apheresis

platelets + Apheresis Plasma

FALSE
FALSE
FALSE
FALSE
FALSE
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date JULY 10,2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on your
license during the period
Information provided by: covered
Bloodbankby the report

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report APRIL TO JUNE 2020

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 1,307
2.3.2 Total number of voluntary non-remunerated donors who donated blood 610
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 59
2.4.2 Temporary deferral 44
2.4.3 Total number of deferrals 103
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 21
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 23
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 59
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 0 Low haemoglobin + Other Medical
2.5.5 Total number of deferrals 103 Conditions + High-risk behaviour +
Travel and other reasons
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 610
2.6.2 Family/replacement donations 697
2.6.3 Paid donations 0 Voluntary non-remunerated donations +
2.6.4 Total number of donations 1,307 Family/replacement donations + Paid d
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 1,032
2.7.2 Female donors 275
2.7.3 Total number of donations 1,307
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 1
2.8.2 Donors aged 18 to 24 years 304
2.8.3 Donors aged 25 to 44 years 828
2.8.4 Donors aged 45 to 64 years 173
 2.8.5 Donors aged 65 years or older 1
2.8.6 Total number of donations 1,307
2.9 How many whole blood donations were collected from first-time voluntary non- 149 Voluntary Non-remunerated
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 1.0000 donations
Total number of non-remunerated
2.11 Are any blood donations collected through apheresis procedures? donors who donated blood
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify):
Voluntary non-remunerated
2.11.5 Total number of apheresis donations apheresis donations +
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement apheresis
during reporting period donations + Paid apheresis donations
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do Douse
you youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 1,080 82.63%
3.4.2 Hepatitis B 1,080 82.63% Total donations screened
3.4.3 Hepatitis C 1,080 82.63% Total donations
3.4.4 Syphilis 1,080 82.63%
3.4.5 Malaria 1,080 82.63%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 0 0.00% 0.00%
3.5.2 Hepatitis B 38 3.52% Screening test
0.00%
reactive
3.5.3 Hepatitis C 7 0.65% Total donations screened
0.00%
3.5.4 Syphilis 15 1.39% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performanceNumber of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
1,080 1,080 1,080 1,080 1,080 1,080
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
 4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external
evaluation of performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separated into
components
5.2 How many whole blood donations were separated into components? 68 5.20% total number of Donations

5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 68
5.3.2 Platelet concentrates 68
5.3.3 Plasma 0
5.3.4 Fresh Frozen Plasma 68
5.3.5 Cryoprecipitate 0
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells 0
5.4.2 Apheresis platelets 0
5.4.3 Apheresis plasma 0 Apheresis red cells + Apheresis
platelets + Apheresis Plasma
5.4.5 Total blood components 0
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 116 14 1 71 58 260
5.11.2 Red cells 0 0 0 0 3 3
5.11.3 Platelets 0 0 0 0 81 81
5.11.4 Plasma 0
5.11.5 Fresh frozen plasma 0 0 0 1 30 31
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 116 14 1 72 172 375
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
 6.5.4 Patients aged 45 to 59 years
6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
se base your
sification on your
se during the period
red by the report

1
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

haemoglobin + Other Medical

ditions + High-risk behaviour +
el and other reasons

ntary non-remunerated donations +

ily/replacement donations + Paid donations
hers
 ntary Non-remunerated
ations
l number of non-remunerated
ors who donated blood
FALSE

ntary non-remunerated
eresis donations +
ily/replacement apheresis
ations + Paid apheresis donations
hers

FALSE

FALSE
1
FALSE
FALSE

l donations screened
l donations

FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
1
 FALSE
FALSE
FALSE

le blood separated into 3

ponents
number of Donations

eresis red cells + Apheresis

elets + Apheresis Plasma

1
1
1
1
1
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date August 20, 2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on you
license during the pe
Information provided by: covered
Bloodbank by the repo

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report July-20

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 672
2.3.2 Total number of voluntary non-remunerated donors who donated blood 596
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 48
2.4.2 Temporary deferral 241
2.4.3 Total number of deferrals 289
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 179
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 62
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 45
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 3 Low haemoglobin +
2.5.5 Total number of deferrals 289 Conditions + High-r
Travel and other rea
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 596
2.6.2 Family/replacement donations 76
2.6.3 Paid donations 0 Voluntary non-remu
2.6.4 Total number of donations 672 Family/replacement
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 542
2.7.2 Female donors 130
 2.7.3 Total number of donations 672
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 1
2.8.2 Donors aged 18 to 24 years 153
2.8.3 Donors aged 25 to 44 years 436
2.8.4 Donors aged 45 to 64 years 82
2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 672
2.9 How many whole blood donations were collected from first-time voluntary non- 234 Voluntary Non-remu
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 0.0000 donations
Total number of non
2.11 Are any blood donations collected through apheresis procedures? donors who donated
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify): Voluntary non-remu
2.11.5 Total number of apheresis donations apheresis donations
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement
during reporting period donations + Paid ap
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do you Douse
youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 660 98.21%
3.4.2 Hepatitis B 660 98.21% Total donations scre
3.4.3 Hepatitis C 660 98.21% Total donations
3.4.4 Syphilis 660 98.21%
3.4.5 Malaria 660 98.21%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 2 0.30% 0.00%
3.5.2 Hepatitis B 31 4.70% Screening test
0.00%
reactive
3.5.3 Hepatitis C 5 0.76% Total donations screened
0.00%
3.5.4 Syphilis 7 1.06% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performance
Number of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
660 660 660 660 660 660
 3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separa
components
5.2 How many whole blood donations were separated into components? 141 20.98% total number of Don
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 141
5.3.2 Platelet concentrates 141
5.3.3 Plasma
5.3.4 Fresh Frozen Plasma 141
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells 0
5.4.2 Apheresis platelets 0
5.4.3 Apheresis plasma 0 Apheresis red cells +
platelets + Apheresi
5.4.5 Total blood components 0
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Total
Problem CHYLOU expiry
S
5.11.1 Whole blood 36 36
5.11.2 Red cells 9
5.11.3 Platelets 9 9
5.11.4 Plasma
5.11.5 Fresh frozen plasma 9
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 63 63
 HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
6.5.4 Patients aged 45 to 59 years
6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
Please base your
classification on your
license during the period
covered
Bloodbank by the report
head

3
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

Low haemoglobin + Other Medical

Conditions + High-risk behaviour +
Travel and other reasons

Voluntary non-remunerated donations +

Family/replacement donations + Paid donations
+ Others
 Voluntary Non-remunerated
donations
Total number of non-remunerated
donors who donated blood
FALSE

Voluntary non-remunerated
apheresis donations +
Family/replacement apheresis
donations + Paid apheresis donations
+ Others

FALSE

FALSE
3
FALSE
FALSE

Total donations screened

Total donations

ning test reactive

donations screened
 FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

Whole blood separated into

FALSE
components
total number of Donations

Apheresis red cells + Apheresis

platelets + Apheresis Plasma

FALSE
FALSE
FALSE
FALSE
FALSE
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date September 20, 2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on you
license during the pe
Information provided by: covered
Bloodbank by the repo

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report August-20

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 677
2.3.2 Total number of voluntary non-remunerated donors who donated blood 626
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 29
2.4.2 Temporary deferral 201
2.4.3 Total number of deferrals 230
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 161
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 40
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 29
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 0 Low haemoglobin +
2.5.5 Total number of deferrals 230 Conditions + High-r
Travel and other rea
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 626
2.6.2 Family/replacement donations 51
2.6.3 Paid donations 0 Voluntary non-remu
2.6.4 Total number of donations 677 Family/replacement
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 555
2.7.2 Female donors 122
 2.7.3 Total number of donations 677
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 0
2.8.2 Donors aged 18 to 24 years 175
2.8.3 Donors aged 25 to 44 years 405
2.8.4 Donors aged 45 to 64 years 97
2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 677
2.9 How many whole blood donations were collected from first-time voluntary non- 231 Voluntary Non-remu
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 0.0000 donations
Total number of non
2.11 Are any blood donations collected through apheresis procedures? donors who donated
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify): Voluntary non-remu
2.11.5 Total number of apheresis donations apheresis donations
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement
during reporting period donations + Paid ap
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do you Douse
youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 566 83.60%
3.4.2 Hepatitis B 566 83.60% Total donations scre
3.4.3 Hepatitis C 566 83.60% Total donations
3.4.4 Syphilis 566 83.60%
3.4.5 Malaria 566 83.60%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 3 0.53% 0.00%
3.5.2 Hepatitis B 20 3.53% Screening test
0.00%
reactive
3.5.3 Hepatitis C 0 0.00% Total donations screened
0.00%
3.5.4 Syphilis 8 1.41% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performance
Number of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
566 566 566 566 566 566
 3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separa
components
5.2 How many whole blood donations were separated into components? 105 15.51% total number of Don
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 105
5.3.2 Platelet concentrates 105
5.3.3 Plasma
5.3.4 Fresh Frozen Plasma 105
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells
5.4.2 Apheresis platelets
5.4.3 Apheresis plasma Apheresis red cells +
platelets + Apheresi
5.4.5 Total blood components
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Total
Problem CHYLOU expiry
S
5.11.1 Whole blood 22 22
5.11.2 Red cells 9 9
5.11.3 Platelets 9 9
5.11.4 Plasma
5.11.5 Fresh frozen plasma 9 9
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 49 0 0 0 49
 HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
6.5.4 Patients aged 45 to 59 years
6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
Please base your
classification on your
license during the period
covered
Bloodbank by the report
head

3
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

Low haemoglobin + Other Medical

Conditions + High-risk behaviour +
Travel and other reasons

Voluntary non-remunerated donations +

Family/replacement donations + Paid donations
+ Others
 Voluntary Non-remunerated
donations
Total number of non-remunerated
donors who donated blood
FALSE

Voluntary non-remunerated
apheresis donations +
Family/replacement apheresis
donations + Paid apheresis donations
+ Others

FALSE

FALSE
3
FALSE
FALSE

Total donations screened

Total donations

ning test reactive

donations screened
 FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

Whole blood separated into

FALSE
components
total number of Donations

Apheresis red cells + Apheresis

platelets + Apheresis Plasma

FALSE
FALSE
FALSE
FALSE
FALSE
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date October 15, 2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on you
license during the pe
Information provided by: covered
Bloodbank by the repo

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report September-20

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 890
2.3.2 Total number of voluntary non-remunerated donors who donated blood 867
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 26
2.4.2 Temporary deferral 214
2.4.3 Total number of deferrals 240
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 157
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 57
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 23
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 3 Low haemoglobin +
2.5.5 Total number of deferrals 240 Conditions + High-r
Travel and other rea
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 867
2.6.2 Family/replacement donations 23
2.6.3 Paid donations 0 Voluntary non-remu
2.6.4 Total number of donations 890 Family/replacement
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 713
2.7.2 Female donors 177
 2.7.3 Total number of donations 890
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 11
2.8.2 Donors aged 18 to 24 years 297
2.8.3 Donors aged 25 to 44 years 448
2.8.4 Donors aged 45 to 64 years 134
2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 890
2.9 How many whole blood donations were collected from first-time voluntary non- 322 Voluntary Non-remu
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 0.0000 donations
Total number of non
2.11 Are any blood donations collected through apheresis procedures? donors who donated
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify): Voluntary non-remu
2.11.5 Total number of apheresis donations apheresis donations
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement
during reporting period donations + Paid ap
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do you Douse
youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 698 78.43%
3.4.2 Hepatitis B 698 78.43% Total donations scre
3.4.3 Hepatitis C 698 78.43% Total donations
3.4.4 Syphilis 698 78.43%
3.4.5 Malaria 698 78.43%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 1 0.14% 0.00%
3.5.2 Hepatitis B 15 2.15% Screening test
0.00%
reactive
3.5.3 Hepatitis C 1 0.14% Total donations screened
0.00%
3.5.4 Syphilis 7 1.00% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performance
Number of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
698 698 698 698 698 698
 3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separa
components
5.2 How many whole blood donations were separated into components? 94 10.56% total number of Don
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 94
5.3.2 Platelet concentrates 94
5.3.3 Plasma
5.3.4 Fresh Frozen Plasma 94
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells
5.4.2 Apheresis platelets
5.4.3 Apheresis plasma Apheresis red cells +
platelets + Apheresi
5.4.5 Total blood components
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Total
Problem CHYLOU expiry
S
5.11.1 Whole blood 21 2 3 83 109
5.11.2 Red cells 1 2 3
5.11.3 Platelets 1 36 37
5.11.4 Plasma
5.11.5 Fresh frozen plasma 1 1 2
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 24 2 3 122 151
 HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
6.5.4 Patients aged 45 to 59 years
6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
Please base your
classification on your
license during the period
covered
Bloodbank by the report
head

3
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

Low haemoglobin + Other Medical

Conditions + High-risk behaviour +
Travel and other reasons

Voluntary non-remunerated donations +

Family/replacement donations + Paid donations
+ Others
 Voluntary Non-remunerated
donations
Total number of non-remunerated
donors who donated blood
FALSE

Voluntary non-remunerated
apheresis donations +
Family/replacement apheresis
donations + Paid apheresis donations
+ Others

FALSE

FALSE
3
FALSE
FALSE

Total donations screened

Total donations

ning test reactive

donations screened
 FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

Whole blood separated into

FALSE
components
total number of Donations

Apheresis red cells + Apheresis

platelets + Apheresis Plasma

FALSE
FALSE
FALSE
FALSE
FALSE
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date OCTOBER 15,2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on your
license during the period
Information provided by: covered
Bloodbankby the report

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report JULY-SEPTEMBER 2020

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 2,239
2.3.2 Total number of voluntary non-remunerated donors who donated blood 2,089
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 103
2.4.2 Temporary deferral 656
2.4.3 Total number of deferrals 759
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 497
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 159
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 97
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 6 Low haemoglobin + Other Medical
2.5.5 Total number of deferrals 759 Conditions + High-risk behaviour +
Travel and other reasons
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 2,089
2.6.2 Family/replacement donations 150
2.6.3 Paid donations 0 Voluntary non-remunerated donations +
2.6.4 Total number of donations 2,239 Family/replacement donations + Paid d
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 1,810
2.7.2 Female donors 429
2.7.3 Total number of donations 2,239
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 12
2.8.2 Donors aged 18 to 24 years 625
2.8.3 Donors aged 25 to 44 years 1,289
2.8.4 Donors aged 45 to 64 years 313
 2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 2239
2.9 How many whole blood donations were collected from first-time voluntary non- 787 Voluntary Non-remunerated
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 0.0000 donations
Total number of non-remunerated
2.11 Are any blood donations collected through apheresis procedures? donors who donated blood
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify): Voluntary non-remunerated
2.11.5 Total number of apheresis donations apheresis donations +
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement apheresis
during reporting period donations + Paid apheresis donations
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do Douse
you youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 1,924 85.93%
3.4.2 Hepatitis B 1,924 85.93% Total donations screened
3.4.3 Hepatitis C 1,924 85.93% Total donations
3.4.4 Syphilis 1,924 85.93%
3.4.5 Malaria 1,924 85.93%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 6 0.31% 0.00%
3.5.2 Hepatitis B 66 3.43% Screening test
0.00%
reactive
3.5.3 Hepatitis C 6 0.31% Total donations screened
0.00%
3.5.4 Syphilis 22 1.14% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performanceNumber of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
1,924 1,924 1,924 1,924 1,924 1,924
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
 4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separated into
components
5.2 How many whole blood donations were separated into components? 340 15.19% total number of Donations
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 340
5.3.2 Platelet concentrates 340
5.3.3 Plasma
5.3.4 Fresh Frozen Plasma 340
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells
5.4.2 Apheresis platelets
5.4.3 Apheresis plasma Apheresis red cells + Apheresis
platelets + Apheresis Plasma
5.4.5 Total blood components
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 79 2 3 83 167
5.11.2 Red cells 19 2 21
5.11.3 Platelets 19 36 55
5.11.4 Plasma
5.11.5 Fresh frozen plasma 19 1 20
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 136 2 3 122 263
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years 48 35
6.5.2 Patients aged 5 to 14 years 46 47
6.5.3 Patients aged 15 to 44 years 451 1,035
 6.5.4 Patients aged 45 to 59 years 316 405
6.5.5 Patients aged 60 years older 386 265
6.5.6 Total number of patients transfused by gender 1,247 1,787
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
se base your
sification on your
se during the period
red by the report

3
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

haemoglobin + Other Medical

ditions + High-risk behaviour +
el and other reasons

ntary non-remunerated donations +

ily/replacement donations + Paid donations
hers
 ntary Non-remunerated
ations
l number of non-remunerated
ors who donated blood
FALSE

ntary non-remunerated
eresis donations +
ily/replacement apheresis
ations + Paid apheresis donations
hers

FALSE

FALSE
3
FALSE
FALSE

l donations screened
l donations

FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
 FALSE
FALSE
FALSE

le blood separated into

FALSE
ponents
number of Donations

eresis red cells + Apheresis

elets + Apheresis Plasma

FALSE
FALSE
FALSE
FALSE
FALSE
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date November 10, 2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on your
license during the period
Information provided by: covered
Bloodbankby the report

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report October-20

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 711
2.3.2 Total number of voluntary non-remunerated donors who donated blood 707
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 40
2.4.2 Temporary deferral 211
2.4.3 Total number of deferrals 251
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 151
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 60
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 36
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 4 Low haemoglobin + Other Medical
2.5.5 Total number of deferrals 251 Conditions + High-risk behaviour +
Travel and other reasons
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 707
2.6.2 Family/replacement donations 4
2.6.3 Paid donations 0 Voluntary non-remunerated donations +
2.6.4 Total number of donations 711 Family/replacement donations + Paid d
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 560
2.7.2 Female donors 151
2.7.3 Total number of donations 711
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 2
2.8.2 Donors aged 18 to 24 years 151
2.8.3 Donors aged 25 to 44 years 460
2.8.4 Donors aged 45 to 64 years 98
 2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 711
2.9 How many whole blood donations were collected from first-time voluntary non- 307 Voluntary Non-remunerated
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 0.0000 donations
Total number of non-remunerated
2.11 Are any blood donations collected through apheresis procedures? donors who donated blood
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations 0
2.11.2 Family/ replacement apheresis donations 0
2.11.3 Paid apheresis donations 0
2.11.4 Others (please specify): 0 Voluntary non-remunerated
2.11.5 Total number of apheresis donations 0 apheresis donations +
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement apheresis
0 donations + Paid apheresis donations
during reporting period
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do Douse
you youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 617 86.78%
3.4.2 Hepatitis B 617 86.78% Total donations screened
3.4.3 Hepatitis C 617 86.78% Total donations
3.4.4 Syphilis 617 86.78%
3.4.5 Malaria 617 86.78%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 0 0.00% 0.00%
3.5.2 Hepatitis B 31 5.02% Screening test
0.00%
reactive
3.5.3 Hepatitis C 2 0.32% Total donations screened
0.00%
3.5.4 Syphilis 4 0.65% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performanceNumber of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
617 617 617 617 617 617
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
 4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separated into
components
5.2 How many whole blood donations were separated into components? 41 5.77% total number of Donations
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 41
5.3.2 Platelet concentrates 41
5.3.3 Plasma
5.3.4 Fresh Frozen Plasma 41
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells 0
5.4.2 Apheresis platelets 0
5.4.3 Apheresis plasma 0 Apheresis red cells + Apheresis
platelets + Apheresis Plasma
5.4.5 Total blood components 0
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 35 3 2 97 44 181
5.11.2 Red cells 2 2
5.11.3 Platelets 2 8 10
5.11.4 Plasma
5.11.5 Fresh frozen plasma 2 2
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 41 3 2 97 52 195
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
 6.5.4 Patients aged 45 to 59 years
6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
se base your
sification on your
se during the period
red by the report

3
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

haemoglobin + Other Medical

ditions + High-risk behaviour +
el and other reasons

ntary non-remunerated donations +

ily/replacement donations + Paid donations
hers
 ntary Non-remunerated
ations
l number of non-remunerated
ors who donated blood
FALSE

ntary non-remunerated
eresis donations +
ily/replacement apheresis
ations + Paid apheresis donations
hers

FALSE

FALSE
3
FALSE
FALSE

l donations screened
l donations

FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
 FALSE
FALSE
FALSE

le blood separated into

FALSE
ponents
number of Donations

eresis red cells + Apheresis

elets + Apheresis Plasma

FALSE
FALSE
FALSE
FALSE
FALSE
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date December 5, 2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on your
license during the period
Information provided by: covered
Bloodbankby the report

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report November-20

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 489
2.3.2 Total number of voluntary non-remunerated donors who donated blood 480
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 40
2.4.2 Temporary deferral 152
2.4.3 Total number of deferrals 192
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 109
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 43
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 40
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) Low haemoglobin + Other Medical
2.5.5 Total number of deferrals 192 Conditions + High-risk behaviour +
Travel and other reasons
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 480
2.6.2 Family/replacement donations 9
2.6.3 Paid donations Voluntary non-remunerated donations +
2.6.4 Total number of donations 489 Family/replacement donations + Paid d
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 350
2.7.2 Female donors 139
2.7.3 Total number of donations 489
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 2
2.8.2 Donors aged 18 to 24 years 142
2.8.3 Donors aged 25 to 44 years 282
2.8.4 Donors aged 45 to 64 years 63
 2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 489
2.9 How many whole blood donations were collected from first-time voluntary non- 219 Voluntary Non-remunerated
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 0.0000 donations
Total number of non-remunerated
2.11 Are any blood donations collected through apheresis procedures? donors who donated blood
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations 0
2.11.2 Family/ replacement apheresis donations 0
2.11.3 Paid apheresis donations 0
2.11.4 Others (please specify): 0 Voluntary non-remunerated
2.11.5 Total number of apheresis donations 0 apheresis donations +
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement apheresis
0 donations + Paid apheresis donations
during reporting period
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do Douse
you youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 618 126.38%
3.4.2 Hepatitis B 618 126.38% Total donations screened
3.4.3 Hepatitis C 618 126.38% Total donations
3.4.4 Syphilis 618 126.38%
3.4.5 Malaria 618 126.38%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 2 0.32% 0.00%
3.5.2 Hepatitis B 26 4.21% Screening test
0.00%
reactive
3.5.3 Hepatitis C 5 0.81% Total donations screened
0.00%
3.5.4 Syphilis 10 1.62% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performanceNumber of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
618 618 618 618 618 618
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
 4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separated into
components
5.2 How many whole blood donations were separated into components? 0 0.00% total number of Donations
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 0
5.3.2 Platelet concentrates 0
5.3.3 Plasma
5.3.4 Fresh Frozen Plasma 0
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells 0
5.4.2 Apheresis platelets 0
5.4.3 Apheresis plasma 0 Apheresis red cells + Apheresis
platelets + Apheresis Plasma
5.4.5 Total blood components 0
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 40 1 1 10 29 81
5.11.2 Red cells
5.11.3 Platelets
5.11.4 Plasma
5.11.5 Fresh frozen plasma
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 40 1 10 29 81
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
 6.5.4 Patients aged 45 to 59 years
6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
se base your
sification on your
se during the period
red by the report

3
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

haemoglobin + Other Medical

ditions + High-risk behaviour +
el and other reasons

ntary non-remunerated donations +

ily/replacement donations + Paid donations
hers
 ntary Non-remunerated
ations
l number of non-remunerated
ors who donated blood
FALSE

ntary non-remunerated
eresis donations +
ily/replacement apheresis
ations + Paid apheresis donations
hers

FALSE

FALSE
3
FALSE
FALSE

l donations screened
l donations

FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
 FALSE
FALSE
FALSE

le blood separated into

FALSE
ponents
number of Donations

eresis red cells + Apheresis

elets + Apheresis Plasma

FALSE
FALSE
FALSE
FALSE
FALSE
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date January 6, 2020
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on your
license during the period
Information provided by: covered
Bloodbankby the report

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report December-20

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 426
2.3.2 Total number of voluntary non-remunerated donors who donated blood 392
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 26
2.4.2 Temporary deferral 89
2.4.3 Total number of deferrals 115
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 30
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 59
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 25
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 1 Low haemoglobin + Other Medical
2.5.5 Total number of deferrals 115 Conditions + High-risk behaviour +
Travel and other reasons
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 392
2.6.2 Family/replacement donations 34
2.6.3 Paid donations 0 Voluntary non-remunerated donations +
2.6.4 Total number of donations 426 Family/replacement donations + Paid d
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 320
2.7.2 Female donors 106
2.7.3 Total number of donations 426
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 0
2.8.2 Donors aged 18 to 24 years 86
2.8.3 Donors aged 25 to 44 years 282
2.8.4 Donors aged 45 to 64 years 58
 2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 426
2.9 How many whole blood donations were collected from first-time voluntary non- 174 Voluntary Non-remunerated
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 0.0000 donations
Total number of non-remunerated
2.11 Are any blood donations collected through apheresis procedures? donors who donated blood
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations 0
2.11.2 Family/ replacement apheresis donations 0
2.11.3 Paid apheresis donations 0
2.11.4 Others (please specify): 0 Voluntary non-remunerated
2.11.5 Total number of apheresis donations 0 apheresis donations +
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement apheresis
0 donations + Paid apheresis donations
during reporting period
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do Douse
you youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 404 94.84%
3.4.2 Hepatitis B 404 94.84% Total donations screened
3.4.3 Hepatitis C 404 94.84% Total donations
3.4.4 Syphilis 404 94.84%
3.4.5 Malaria 404 94.84%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 1 0.25% 0.00%
3.5.2 Hepatitis B 17 4.21% Screening test
0.00%
reactive
3.5.3 Hepatitis C 2 0.50% Total donations screened
0.00%
3.5.4 Syphilis 6 1.49% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performanceNumber of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
404 404 404 404 404 404
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
 4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separated into
components
5.2 How many whole blood donations were separated into components? 0 0.00% total number of Donations
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 0
5.3.2 Platelet concentrates 0
5.3.3 Plasma
5.3.4 Fresh Frozen Plasma 0
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells 0
5.4.2 Apheresis platelets 0
5.4.3 Apheresis plasma 0 Apheresis red cells + Apheresis
platelets + Apheresis Plasma
5.4.5 Total blood components 0
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 36 2 5 19 62
5.11.2 Red cells 0
5.11.3 Platelets 0
5.11.4 Plasma
5.11.5 Fresh frozen plasma 15 15
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 36 2 0 5 34 77
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
 6.5.4 Patients aged 45 to 59 years
6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
se base your
sification on your
se during the period
red by the report

3
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

haemoglobin + Other Medical

ditions + High-risk behaviour +
el and other reasons

ntary non-remunerated donations +

ily/replacement donations + Paid donations
hers
 ntary Non-remunerated
ations
l number of non-remunerated
ors who donated blood
FALSE

ntary non-remunerated
eresis donations +
ily/replacement apheresis
ations + Paid apheresis donations
hers

FALSE

FALSE
3
FALSE
FALSE

l donations screened
l donations

FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
 FALSE
FALSE
FALSE

le blood separated into

FALSE
ponents
number of Donations

eresis red cells + Apheresis

elets + Apheresis Plasma

FALSE
FALSE
FALSE
FALSE
FALSE
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2019
v.1.1
Program
Section 1: Administrative Information
1.1 Date January 8, 2021
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on your
license during the period
Information provided by: covered
Bloodbankby the report

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report OCTOBER-DECEMBER 2020

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment
2.1.2 Pre-donation counselling and donor selection
2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling ●

2.2 Do you maintain records of the following

2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 1,626
2.3.2 Total number of voluntary non-remunerated donors who donated blood 1,579
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 106
2.4.2 Temporary deferral 452
2.4.3 Total number of deferrals 558
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 290
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 162
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 101
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 5 Low haemoglobin + Other Medical
2.5.5 Total number of deferrals 558 Conditions + High-risk behaviour +
Travel and other reasons
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 1,579
2.6.2 Family/replacement donations 47
2.6.3 Paid donations 0 Voluntary non-remunerated donations +
2.6.4 Total number of donations 1,626 Family/replacement donations + Paid d
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 1,230
2.7.2 Female donors 396
2.7.3 Total number of donations 1,626
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 4
2.8.2 Donors aged 18 to 24 years 379
2.8.3 Donors aged 25 to 44 years 1,024
2.8.4 Donors aged 45 to 64 years 219
 2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 1626
2.9 How many whole blood donations were collected from first-time voluntary non- 700 Voluntary Non-remunerated
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 0.0000 donations
Total number of non-remunerated
2.11 Are any blood donations collected through apheresis procedures? donors who donated blood
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations 0
2.11.2 Family/ replacement apheresis donations 0
2.11.3 Paid apheresis donations 0
2.11.4 Others (please specify): 0 Voluntary non-remunerated
2.11.5 Total number of apheresis donations 0 apheresis donations +
2.11.6 Total number of donors who donated through apheresis procedures Family/replacement apheresis
0 donations + Paid apheresis donations
during reporting period
2.12 Do you have a system for post-donation counselling of blood donors who test positive + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion
transmissible infections?
3.1.1
Do Douse
you youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for
3.2 laboratory screening of blood donations for transfusion transmissible
Do you participate in an external quality assessment scheme/external
3.3 infections?
evaluation or performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-
transmissible infections?
3.4.1 HIV 1,639 100.80%
3.4.2 Hepatitis B 1,639 100.80% Total donations screened
3.4.3 Hepatitis C 1,639 100.80% Total donations
3.4.4 Syphilis 1,639 100.80%
3.4.5 Malaria 1,639 100.80%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 3 0.18% 0.00%
3.5.2 Hepatitis B 74 4.51% Screening test
0.00%
reactive
3.5.3 Hepatitis C 9 0.55% Total donations screened
0.00%
3.5.4 Syphilis 20 1.22% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performanceNumber of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
1,639 1,639 1,639 1,639 1,639 1,639 ● ●

3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
 4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? Whole blood separated into
components
5.2 How many whole blood donations were separated into components? 41 2.52% total number of Donations
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 41
5.3.2 Platelet concentrates 41
5.3.3 Plasma
5.3.4 Fresh Frozen Plasma 41
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells 0
5.4.2 Apheresis platelets 0
5.4.3 Apheresis plasma 0 Apheresis red cells + Apheresis
platelets + Apheresis Plasma
5.4.5 Total blood components 0
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage problem/ Date
TTI Problem Problem CHYLOU
Total
expiry
S
5.11.1 Whole blood 111 6 3 112 92 324
5.11.2 Red cells 2 2
5.11.3 Platelets 2 8 10
5.11.4 Plasma 0
5.11.5 Fresh frozen plasma 2 2
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 117 6 3 112 100 338
HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions
for compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years 22 15
6.5.2 Patients aged 5 to 14 years 28 20
6.5.3 Patients aged 15 to 44 years 246 720
 6.5.4 Patients aged 45 to 59 years 320 241
6.5.5 Patients aged 60 years older 298 245
6.5.6 Total number of patients transfused by gender 914 1241
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
se base your
sification on your
se during the period
red by the report

3
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

haemoglobin + Other Medical

ditions + High-risk behaviour +
el and other reasons

ntary non-remunerated donations +

ily/replacement donations + Paid donations
hers
 ntary Non-remunerated
ations
l number of non-remunerated
ors who donated blood
FALSE

ntary non-remunerated
eresis donations +
ily/replacement apheresis
ations + Paid apheresis donations
hers

FALSE

FALSE
3
FALSE
FALSE

l donations screened
l donations

FALSE FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
 FALSE
FALSE
FALSE

le blood separated into

FALSE
ponents
number of Donations

eresis red cells + Apheresis

elets + Apheresis Plasma

FALSE
FALSE
FALSE
FALSE
FALSE
 National Voluntary Blood Services
Blood Safety Indicators Report Form 2018
v.1.1
Program
Section 1: Administrative Information
1.1 Date JANUARY 8,2021
1.2 Region 12
1.3 Blood Service Facility/ Hospital Kidapawan City Blood Center Please base your
1.4 Classification Blood Center classification on you
license during the p
Information provided by: covered
Bloodbankby the repo

1.5 Name Dr. Nena S. Lingayon, AP-CP head

1.6 Position Pathologist

1.7 Organization LGU-Kidapawan City
1.8 Address Quezon Blvd., Kidapawan City, North Cotabato 9400
1.9 Tel. no. (064) 5773381
1.10 Fax no. (064) 5771377
1.11 E-mail kidapawancitybloodcenter@gmail.com
1.12 Period covered by report JANUARY-DECEMBER 2020

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment ●

2.1.2 Pre-donation counselling and donor selection ●

2.1.3 Blood collection and donor care ●

2.1.4 Post-donation counselling ●

2.2 Do you maintain records of the following

2.2.1 Blood donor recruitment ●

2.2.2 Pre-donation counselling and donor selection ●

2.2.3 Blood collection and donor care ●

2.2.4 Post-donation counselling ●

2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 7,377
2.3.2 Total number of voluntary non-remunerated donors who donated blood 6,696
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 403
2.4.2 Temporary deferral 1,816
2.4.3 Total number of deferrals 2,219
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 1,330
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 486
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 391
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 12 Low haemoglobin +
2.5.5 Total number of deferrals 2,219 Conditions + High-r
Travel and other rea
2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 6,696
2.6.2 Family/replacement donations 681
2.6.3 Paid donations 0 Voluntary non-remu
2.6.4 Total number of donations 7,377 Family/replacemen
+ Others
2.7 How many whole blood donations were collected from:
2.7.1 Male donors 5,867
2.7.2 Female donors 1,510
 2.7.3 Total number of donations 7,377
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 35
2.8.2 Donors aged 18 to 24 years 1,856
2.8.3 Donors aged 25 to 44 years 4,465
2.8.4 Donors aged 45 to 64 years 1,020
2.8.5 Donors aged 65 years or older 1
2.8.6 Total number of donations 7,377
2.9 How many whole blood donations were collected from first-time voluntary non- 2,546 Voluntary Non-rem
remunerated donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors 1.0000 donations
Total number of non
2.11 Are any blood donations collected through apheresis procedures? ● donors who donate
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations 0
2.11.2 Family/ replacement apheresis donations 0
2.11.3 Paid apheresis donations 0
2.11.4 Others (please specify): 0 Voluntary non-remu
2.11.5 Total number of apheresis donations 0 apheresis donations
2.11.6 Total number of donors who donated through apheresis procedures Family/replacemen
0 donations + Paid ap
during reporting period
2.12 Do you have a system for post-donation counselling of blood donors who test positive ● + Others
for transfusion-transmissible infections?

Section 3: Screening for transfusion-transmissible infections

3.1 Do you perform laboratory screening of blood donations for transfusion ●
transmissible infections?
3.1.1
Do you Douse
youstandard
use EIA operating
for screening blood donations
procedures for TTIs?
or local written instructions for ●

3.2 laboratory screening of blood donations for transfusion transmissible ●

3.3 Do you participate

infections? in an external quality assessment scheme/external ●
evaluation
How many or performance
donations (wholeforblood
transfusion-transmissible
and apheresis) were infections?
screened for the following transfusion-
3.4
transmissible infections?
3.4.1 HIV 7,028 95.27%
3.4.2 Hepatitis B 7,028 95.27% Total donations scre
3.4.3 Hepatitis C 7,028 95.27% Total donations
3.4.4 Syphilis 7,028 95.27%
3.4.5 Malaria 7,028 95.27%
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b)
positive in the confirmatory test? Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 21 0.30% 0.00%
3.5.2 Hepatitis B 279 3.97% Screening test 0.00%
reactive
3.5.3 Hepatitis C 25 0.36% Total donations screened
0.00%
3.5.4 Syphilis 77 1.10% 0.00%
3.5.5 Malaria 0 0.00% 0.00%
What was the prevalence of the following TTI markers in donated blood during the reporting
3.6
period?
3.6.1 HIV 0.00%
3.6.2 Hepatitis B 0.00%
3.6.3 Hepatitis C 0.00%
3.6.4 Syphilis 0.00%
3.6.5 Malaria 0.00%
Details in which screening for TTIs is performed: number of donations tested, use of standard
3.7 operating procedures (SOPs) and participation in external quality assessment/external evaluation
of Total
performance
Number of donations screened for each TTI SOPs used Participate in EQA
donation
s HIV HBV HCV Syphilis Malaria Yes No Yes No
7,028 7,028 7,028 7,028 7,028 7,028
 3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents ●

3.8.2 Emergency situations ●

3.8.3 Staff shortages ●

3.8.4 Equipment failure/breakdown/power loss ●

3.8.5 Other reasons (please specify) ●

Section 4: Blood group serology testing of blood donations

4.1 Do you perform blood group serology testing of blood donations? ●

4.1.1 Do you use tube method for blood group serology testing? ●

4.2 Do you use standard operating procedures or local written instructions for blood group serology
testing of blood donations?
●

4.3 Do you maintain records of blood group serology testing? ●

4.4 Do you participate in an external quality assessment scheme/external evaluation of ●

performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components? ● Whole blood separa
components
5.2 How many whole blood donations were separated into components? 830 11.25% total number of Don
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 830
5.3.2 Platelet concentrates 830
5.3.3 Plasma
5.3.4 Fresh Frozen Plasma 830
5.3.5 Cryoprecipitate
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells 0
5.4.2 Apheresis platelets 0
5.4.3 Apheresis plasma 0 Apheresis red cells
platelets + Apheres
5.4.5 Total blood components 0
5.5 Do you use standard operating procedures or local written instructions for the
●
preparation of blood components?
5.6 Do you maintain records of blood component preparation? ●

5.7 Do you store whole blood and whole blood components in temperature-monitored ●
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored ●
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment? ●

5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?

Component Reason for discard

Transport
Processing Storage Date
TTI Problem problem/ Total
Problem
CHYLOUS expiry

5.11.1 Whole blood 350 18 7 207 214 796

5.11.2 Red cells 46 2 1 2 51
5.11.3 Platelets 46 3 6 88 143
5.11.4 Plasma 0
5.11.5 Fresh frozen plasma 46 8 6 5 2 67
5.11.6 Cryoprecipitate
5.11.7 Total component discarded 488 31 14 218 306 1,057
 HOSPITAL BLOOD STATIONS 1ST QUARTER REPORT
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions for
compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external
evaluation of performance
6.2.4 Do you for compatibility
store whole blood testing?
and whole blood components in temperature-
monitored equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years 112 99
6.5.2 Patients aged 5 to 14 years 149 146
6.5.3 Patients aged 15 to 44 years 1,271 3,286
6.5.4 Patients aged 45 to 59 years 1,132 1,117
6.5.5 Patients aged 60 years older 1,285 1,007
6.5.6 Total number of patients transfused by gender 3,949 5,655
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?

Comment (optional)
Please base your
classification on your
license during the period
covered
Bloodbankby the report
head

3
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE

Low haemoglobin + Other Medical

Conditions + High-risk behaviour +
Travel and other reasons

Voluntary non-remunerated donations +

Family/replacement donations + Paid donations
+ Others
 Voluntary Non-remunerated
donations
Total number of non-remunerated
donors who donated blood
FALSE

Voluntary non-remunerated
apheresis donations +
Family/replacement apheresis
donations + Paid apheresis donations
+ Others

FALSE

FALSE
3
FALSE
FALSE

Total donations screened

Total donations

ning test reactive

donations screened
 FALSE
FALSE
FALSE
FALSE
FALSE

FALSE
FALSE
FALSE
FALSE
FALSE

Whole blood separated into

FALSE
components
total number of Donations

Apheresis red cells + Apheresis

platelets + Apheresis Plasma

FALSE
FALSE
FALSE
FALSE
FALSE